An Observational Study of Pegasys (Peginterferon Alfa-2a) in Patients With HBeAg-Positive or HBeAg-Negative Chronic Hepatitis B
NCT01734018
·
clinicaltrials.gov ↗
COMPLETED
Status
50
Enrollment
INDUSTRY
Sponsor class
Conditions
Hepatitis B, Chronic
Sponsor
Hoffmann-La Roche